Barchas Isaac
Director
3 filings on record here, covering IMNM. Amounts are the ranges the filer reported, which is how the law requires them to be disclosed.
Filings
CORPORATEFiled 2026-08-12
| Sell | IMNM | Immunome Inc. | $263,959 |
| Sell | IMNM | Immunome Inc. | $1,633,893 |
| Sell | IMNM | Immunome Inc. | $301,058 |
CORPORATEFiled 2026-07-07
| Sell | IMNM | Immunome Inc. | $2,003,396 |
| Sell | IMNM | Immunome Inc. | $409,125 |
CORPORATEFiled 2026-07-02
| Sell | IMNM | Immunome Inc. | $2,134,176 |
| Sell | IMNM | Immunome Inc. | $1,691,113 |
| Sell | IMNM | Immunome Inc. | $567,736 |
Source records are public filings: House and Senate periodic
transaction reports, Office of Government Ethics filings, and SEC Form 4 filings. Amounts
are reported as ranges by law, not exact figures, and filings arrive on a legal delay.
Eltrove reports what was filed. Nothing here is investment advice or a recommendation.